Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Asthenia
ADR ID BADD_A00362
ADR Hierarchy
08      General disorders and administration site conditions
08.01      General system disorders NEC
08.01.01      Asthenic conditions
08.01.01.001      Asthenia
Description Clinical sign or symptom manifested as debility, or lack or loss of strength and energy. [MeSH]
MedDRA Code 10003549
MeSH ID D001247; D009440; D000073496
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Adynamia | Asthenia | Collapse of legs | Debility | Debility marked | Debility, unspecified | Feeling of total lack of energy | Feelings of weakness | General debility | Loss of energy | Nervous debility | Neurasthaenia | Neurasthenia | Strength loss of | Weakness | Weakness generalised | Weakness generalized | Weakness postural | Energy decreased | Frailty | Weakness worsened | Hyposthenia | Cerebro-asthenic syndrome
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00181Atomoxetine hydrochloride--
BADD_D00182Atorvastatin calcium--
BADD_D00186Atovaquone--
BADD_D00189Atropine--
BADD_D00190Atropine sulfate--
BADD_D00192Avanafil--
BADD_D00193Axitinib0.022307%
BADD_D00194Azacitidine0.004164%
BADD_D00195Azathioprine0.006579%
BADD_D00198Azelastine--
BADD_D00200Azilsartan--
BADD_D00201Azilsartan kamedoxomil0.000152%
BADD_D00202Azilsartan medoxomil--
BADD_D00203Azithromycin--
BADD_D00204Azithromycin dihydrate--
BADD_D00205Azithromycin monohydrate--
BADD_D00206Aztreonam--
BADD_D00209Baclofen--
BADD_D00210Balsalazide--
BADD_D00213Barium sulfate--
BADD_D00214Basiliximab--
BADD_D00225Belinostat--
BADD_D00227Benazepril--
BADD_D00228Benazepril hydrochloride--
BADD_D00229Benazeprilat-
BADD_D00230Bendamustine0.001119%
BADD_D00231Bendamustine hydrochloride--
BADD_D00232Bendroflumethiazide--
BADD_D00233Benicar hydrochlorothiazide--
BADD_D00235Benzalkonium chloride--
The 4th Page    First    Pre   4 5 6 7 8    Next   Last    Total 47 Pages
ADReCS-Target
ADR Term Drug Name Target